217 related articles for article (PubMed ID: 10469855)
1. Effect of calcitriol and age on recovery from hypocalcemia in hemodialysis patients.
Borrego MJ; Martin-Malo A; Almaden Y; Rodriguez M; Aljama P; Felsenfeld AJ
Am J Kidney Dis; 1999 Sep; 34(3):456-63. PubMed ID: 10469855
[TBL] [Abstract][Full Text] [Related]
2. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease.
Felsenfeld AJ; Ross D; Rodriguez M
J Am Soc Nephrol; 1991 Dec; 2(6):1136-43. PubMed ID: 1777594
[TBL] [Abstract][Full Text] [Related]
3. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.
Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ
Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908
[TBL] [Abstract][Full Text] [Related]
4. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches.
Ouseph R; Leiser JD; Moe SM
J Am Soc Nephrol; 1996 Mar; 7(3):497-505. PubMed ID: 8704117
[TBL] [Abstract][Full Text] [Related]
7. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Huang CY; Zheng CM; Wu CC; Lo L; Lu KC; Chu P
Nephron Clin Pract; 2012; 122(3-4):93-101. PubMed ID: 23635416
[TBL] [Abstract][Full Text] [Related]
8. The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.
Rodriguez M; Felsenfeld AJ; Williams C; Pederson JA; Llach F
J Am Soc Nephrol; 1991 Nov; 2(5):1014-20. PubMed ID: 1760537
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism.
Costa AF; dos Reis LM; Ribeiro MC; Moysés RM; Jorgetti V
Nephrol Dial Transplant; 2003 Apr; 18(4):743-9. PubMed ID: 12637644
[TBL] [Abstract][Full Text] [Related]
11. Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients.
Yasuda M; Akiba T; Nihei H
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S108-11. PubMed ID: 12612965
[TBL] [Abstract][Full Text] [Related]
12. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.
Dunlay R; Rodriguez M; Felsenfeld AJ; Llach F
Kidney Int; 1989 Dec; 36(6):1093-8. PubMed ID: 2601258
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E
Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy.
Schindler S; Mannstadt M; Urena P; Segre GV; Stein G
Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031
[TBL] [Abstract][Full Text] [Related]
16. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
17. Control of parathyroid function in patients with a short history of hemodialysis.
Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
[TBL] [Abstract][Full Text] [Related]
18. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Greenbaum LA; Grenda R; Qiu P; Restaino I; Wojtak A; Paredes A; Benador N; Melnick JZ; Williams LA; Salusky IB
Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
[TBL] [Abstract][Full Text] [Related]
19. A single parathyroid hormone level obtained 4 hours after total thyroidectomy predicts the need for postoperative calcium supplementation.
Carr AA; Yen TW; Fareau GG; Cayo AK; Misustin SM; Evans DB; Wang TS
J Am Coll Surg; 2014 Oct; 219(4):757-64. PubMed ID: 25053220
[TBL] [Abstract][Full Text] [Related]
20. Dynamic follow-up of the intact parathormone levels in hemodialysis patients treated with Rocaltrol and calcium.
Dimitrakov D; Koumtchev E; Dimitrova R; Stavrev P
Folia Med (Plovdiv); 1998; 40(4):48-53. PubMed ID: 10371800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
